Related Experiment Video
Updated: Feb 19, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Methylxanthine derivative, pentoxifylline attenuates inflammation via NF-κB and AP-1 pathway inhibition in murine
E H T Thulshan Jayathilaka1, Moon-Moo Kim1
1Department of Cosmetics Engineering, and Graduate School of Applied Chemistry·Food Engineering, Dong-Eui University, Busan 47340, Republic of Korea.
Abstract:
The prolonged use of current anti-inflammatory therapies has significant limitations for chronic inflammation management, requiring safer alternatives. In this study, we investigated the anti-inflammatory effect of methylxanthine derivative, pentoxifylline. MTT assay was used for the determination of the cytotoxicity of pentoxifylline. Lipopolysaccharide (LPS)-stimulated murine macrophage RAW 264.7 cells were used for the determination of the anti-inflammatory effect of pentoxifylline using Griess assay, qRT-PCR, Western blot, gene reporter assay and cell migration assay. Pentoxifylline exhibited a high level of safe therapeutic window with no cytotoxicity up to 20 μM in the MTT assay on RAW 264.7 cells. Pentoxifylline demonstrated concentration and time-dependent anti-inflammatory effects with significantly (p < 0.05) reduced NO production at 10 and 20 μM concentrations. Gene expression revealed significant downregulation of inflammatory mediator genes: Nos2, Tnfα, and Il1β (p < 0.05). Protein analysis confirmed these effects with reductions in iNOS, TNFα, IL1β, and IL6 (p < 0.05). Pentoxifylline caused a significant reduction (p < 0.05) of transcriptional activity of NF-κB and AP-1. Further, a significant reduction of nuclear translocation of NF-κB by pentoxifylline confirmed the transcriptional inhibition. Additionally, in the scratch assay, pentoxifylline exhibited a significant reduction (p < 0.05) in macrophage migration, supporting its role in inhibiting inflammation progression. These comprehensive multi-target anti-inflammatory effects of pentoxifylline support its promising potential for use as a therapeutic candidate for inflammatory diseases.
Insights
Pentoxifylline, a safe methylxanthine derivative, effectively reduces inflammation by inhibiting key inflammatory mediators and pathways. This study highlights its potential as a novel therapeutic for chronic inflammatory diseases.
Area of Science:
- Pharmacology
- Immunology
- Cell Biology
Background:
- Current anti-inflammatory therapies have limitations for chronic inflammation.
- Safer alternatives are needed for managing chronic inflammatory conditions.
Purpose of the Study:
- To investigate the anti-inflammatory effects of pentoxifylline, a methylxanthine derivative.
- To evaluate the safety and efficacy of pentoxifylline in cellular models of inflammation.
Main Methods:
- Cytotoxicity assessed using MTT assay on RAW 264.7 cells.
- Anti-inflammatory effects evaluated via Griess assay, qRT-PCR, Western blot, gene reporter assays, and scratch assays.
- Lipopolysaccharide (LPS)-stimulated murine macrophage RAW 264.7 cells were utilized.
Main Results:
- Pentoxifylline demonstrated no cytotoxicity up to 20 μM.
- Reduced nitric oxide (NO) production, inflammatory gene expression (Nos2, Tnfα, Il1β), and protein levels (iNOS, TNFα, IL1β, IL6).
- Inhibited NF-κB and AP-1 transcriptional activity and NF-κB nuclear translocation, reducing macrophage migration.
Conclusions:
- Pentoxifylline exhibits significant multi-target anti-inflammatory effects.
- Demonstrates a safe therapeutic window and potential for treating inflammatory diseases.
- Its ability to inhibit key inflammatory pathways and cell migration supports its therapeutic promise.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...

